Isoprenoids and Cancer

Authors

Raymond J. Hohl, MD, PhD, Penn State Hershey Cancer InstituteFollow

Document Type

Presentation

Presentation Date

6-11-2014

Abstract

Objectives:

1. Global understanding of isoprenoids, their metabolism, and interface with disease.

2. Relate the clinical activity to underlying mechanisms of action(s) at the cellular and biochemical levels.

3. Know the relatively unique clinical pharmacology features associated with these agents.

4. Understand opportunities for new applications of these agents.

Presentation: 62 minutes

Recommended Citation

Hohl, MD, PhD, Raymond J., "Isoprenoids and Cancer" (2014). Kimmel Cancer Center Papers, Presentations, and Grand Rounds. Paper 14.
https://jdc.jefferson.edu/kimmelgrandrounds/14